PRECEDE BIOSCIENCES, INC.

Description: Class 5: Diagnostic assays and reagents for clinical and medical use, namely, for the testing of body fluids; diagnostic chemical, biochemical and biological preparations for medical purposes, namely, for treating and preventing cancers and other clinical pathologies; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers
Class 42: Software as a service (SAAS) services featuring software for inputting, accessing, viewing, processing and analyzing medical data; data as a service (DAAS) services featuring non-downloadable software for the provision of data, namely, for inputting, accessing, viewing, processing and analyzing medical data; computer services, namely, providing data as a service (DaaS) services featuring non-downloadable software for analyzing and managing data for purposes of drug development and discovery; computer services, namely, the provision of data as a service (DaaS) in the pharmaceuticals and healthcare fields for analyzing medical research data information in relation to pharmaceutical drug discovery and drug development; pharmaceutical research and development; pharmaceutical drug development and drug discovery services; medical research and scientific research; providing medical and scientific research information in the field of pharmaceuticals research and development of technology in the field of pharmaceuticals; biomedical research services; product development in the field of pharmaceuticals, namely, the development of preclinical and therapeutic product
Class 44: Medical testing and diagnostic services; clinical pathology services, namely, medical pathology services; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons in the nature of genomic and epigenomic profiling of human biological samples; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services; diagnostics services, namely, the recommendation of medical treatment for identified disease states

Description: Medical testing and diagnostic services; clinical pathology services, namely, medical pathology services; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons in the nature of genomic and epigenomic profiling of human biological samples; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services; diagnostics services, namely, the recommendation of medical treatment for identified disease states; "BIO"; Software as a service (SAAS) services featuring software for inputting, accessing, viewing, processing and analyzing medical data; data as a service (DAAS) services featuring non-downloadable software for the provision of data, namely, for inputting, accessing, viewing, processing and analyzing medical data; computer services, namely, providing data as a service (DaaS) services featuring non-downloadable software for analyzing and managing data for purposes of drug development and discovery; computer services, namely, the provision of data as a service (DaaS) in the pharmaceuticals and healthcare fields for analyzing medical research data information in relation to pharmaceutical drug discovery and drug development; pharmaceutical research and development; pharmaceutical drug development and drug discovery services; medical research and scientific research; providing medical and scientific research information in the field of pharmaceuticals research and development of technology in the field of pharmaceuticals; biomedical research services; product development in the field of pharmaceuticals, namely, the development of preclinical and therapeutic product

Description: Medical testing and diagnostic services; clinical pathology services, namely, medical pathology services; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons in the nature of genomic and epigenomic profiling of human biological samples; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services; diagnostics services, namely, the recommendation of medical treatment for identified disease states; "BIOSCIENCES"; Software as a service (SAAS) services featuring software for inputting, accessing, viewing, processing and analyzing medical data; data as a service (DAAS) services featuring non-downloadable software for the provision of data, namely, for inputting, accessing, viewing, processing and analyzing medical data; computer services, namely, providing data as a service (DaaS) services featuring non-downloadable software for analyzing and managing data for purposes of drug development and discovery; computer services, namely, the provision of data as a service (DaaS) in the pharmaceuticals and healthcare fields for analyzing medical research data information in relation to pharmaceutical drug discovery and drug development; pharmaceutical research and development; pharmaceutical drug development and drug discovery services; medical research and scientific research; providing medical and scientific research information in the field of pharmaceuticals research and development of technology in the field of pharmaceuticals; biomedical research services; product development in the field of pharmaceuticals, namely, the development of preclinical and therapeutic product

Description: Class 5: Diagnostic assays and reagents for clinical and medical use, namely, for the testing of body fluids; diagnostic chemical, biochemical and biological preparations for medical purposes, namely, for treating and preventing cancers and other clinical pathologies; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers
Class 10: Testing instruments for medical diagnostic purposes, namely, instruments for medical diagnostic testing in the fields of cancer; medical devices, namely, automated medical diagnostic image analyzers featuring a system consisting of computer hardware and software as a component of the medical devices, for use in detecting epigenetic signatures in the field of clinical pathology; diagnostic test kits consisting primarily of probes, buffer and reagents for use in microbial testing

Description: "BIO"

Description: Diagnostic assays and reagents for clinical and medical use, namely, for the testing of body fluids; diagnostic chemical, biochemical and biological preparations for medical purposes, namely, for treating and preventing cancers and other clinical pathologies; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers; "BIOSCIENCES"; testing instruments for medical diagnostic purposes, namely, instruments for medical diagnostic testing in the fields of cancer; medical devices, namely, automated medical diagnostic image analyzers featuring a system consisting of computer hardware and software as a component of the medical devices, for use in detecting epigenetic signatures in the field of clinical pathology; diagnostic test kits consisting primarily of probes, buffer and reagents for use in microbial testing

Description: "BIOSCIENCES"

Description: Diagnostic assays and reagents for clinical and medical use, namely for the testing of body fluids; diagnostic chemical, biochemical and biological preparations for medical purposes, namely for treating and preventing cancers and other clinical pathologies; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely cancers; medical testing and diagnostic services, namely, testing for medical diagnostic or treatment purposes in the field of cancer, autoimmune disease, maternal fetal medicine; clinical pathology services, namely, medical testing for diagnostic or treatment purposes in the field of clinical pathology; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services; testing instruments for medical diagnostic purposes, namely, instruments for medical diagnostic testing in the field of cancer; medical devices, namely, automated medical diagnostic image analyzers featuring a system consisting of computer hardware as a component of the medical devices, for use in detecting epigenetic signatures in the field of clinical pathology; diagnostic testing kits consisting primarily of probes, buffer, and reagent for use in microbial testing

Description: Diagnostic assays and reagents for clinical and medical use, namely for the testing of body fluids; diagnostic chemical, biochemical and biological preparations for medical purposes, namely for treating and preventing cancers and other clinical pathologies; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely cancers; medical testing and diagnostic services, namely, testing for medical diagnostic or treatment purposes in the field of cancer, autoimmune disease, maternal fetal medicine; clinical pathology services, namely, medical testing for diagnostic or treatment purposes in the field of clinical pathology; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services; "DIAGNOSTICS"; testing instruments for medical diagnostic purposes, namely, instruments for medical diagnostic testing in the field of cancer; medical devices, namely, automated medical diagnostic image analyzers featuring a system consisting of computer hardware as a component of the medical devices, for use in detecting epigenetic signatures in the field of clinical pathology; diagnostic testing kits consisting primarily of probes, buffer, and reagent for use in microbial testing